Overactive Bladder: Diagnosis and Treatment - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Overactive Bladder: Diagnosis and Treatment

Description:

A third of the patients with OAB will also have urge urinary incontinence. ... Urge Incontinence. 45% of patients completely dry ... – PowerPoint PPT presentation

Number of Views:1469
Avg rating:3.0/5.0
Slides: 20
Provided by: elizabeth53
Category:

less

Transcript and Presenter's Notes

Title: Overactive Bladder: Diagnosis and Treatment


1
Overactive BladderDiagnosis and Treatment Chase
Kenyon Sovell, MD Urology Associates May 30th,
2007 Pearls of Plumbing Seminar
2
Overview of Bladder Problems
  • Cant void
  • Void too often
  • Urinary leakage

3
Bladder Function
  • Storage phase
  • Actively relaxes to store urine.
  • Majority of time spent in this phase.
  • Emptying phase
  • Coordinated sphincter relaxation and bladder
    contraction.

4
A Spectrum of Symptoms
Overactive Bladder
  • Frequency
  • Urgency

z
Incontinence
Stress Incont.
UrgeIncont.
Mixed Incont.
Minimally Invasive Surgery
Medications Neuromodulation
5
What is Overactive Bladder (OAB)?
  • Defined as a compelling desire to void that is
    difficult to deter.
  • gt8 times per day, gt2 times per night
  • A third of the patients with OAB will also have
    urge urinary incontinence.
  • Absence of urinary tract infection or
    neurological condition (Multiple Sclerosis,
    Parkinsons Disease).

6
Prevalence of OAB in the United StatesEstimated
to Impact 33 Million Americans
75
65-74
55-64
Age (years)
45-54
35-44
Men
25-34
Women
N 5,204
18-24
0
5
10
15
20
25
30
35
40
Prevalence ()
National Center for Health Statistics. Vital
Health Stat. 200210209.Stewart W et al. World
J Urol. 200320327-336.
7
Diagnostic Evaluation
  • Medical History
  • Hematuria, pelvic surgery or radiation,
    infections
  • Physical Exam
  • Office cystoscopy to exclude malignancy or
    stones.
  • Office tests
  • Urine Analysis, post void residual urine
    assessment, Uro-flow and PSA (in men)
  • Urodynamic testing
  • A 48 hour Voiding Diary
  • Questionnaire

8
Treatment Options for OAB
  • Dietary
  • Reducing bladder irritants such as caffeine,
    alcohol, nicotine.
  • Behavioral Modification
  • Review of the Voiding Diary, biofeedback.
  • Pharmacotherapy anticholinergics
  • Ditropan, Detrol, Enablex, Sanctura, Vesicare.
  • Minimally Invasive Treatments
  • Botox
  • Neuromodulation (InterStim)

9
Medicines Anticholinergics
  • Heavily marketed medicines
  • Detrol
  • Vesicare
  • Enablex
  • Sanctura
  • Oxytrol
  • Ditropan
  • These medicines help relax the bladder.
  • They work by blocking receptors in the bladder.

10
Adverse Reactions to Medications
  • Dry mouth or eyes (20-45)
  • Constipation (6-21)
  • Headache (4-8)

11
Drug Therapy Persistence is Poor Among OAB
Patients
Prescription persistency rates of OAB medications
among patients new to market (n21,362)
This data is dated from 2002 and current numbers
would likely be better, but only marginally.
Source The 2002 Gallup Study of the Market for
Prescription Incontinence Medication. Princeton,
NJ Multi-Sponsor Surveys, Inc 2002
12
InterStim Therapy for Urinary Control
  • FDA-approved treatment for urinary control
    problems in people who have not had success with
    behavioral modification or medications.
  • Over 30,000 patients implanted worldwide

13
Test Stimulation
  • A test is done to determine the respond to the
    stimulus.
  • Performed in the office (20 minutes).
  • A lead is placed under the skin just above the
    tailbone
  • Lead is connected to an external device (size of
    a pager) for a period of 2-3 days.
  • The decision for implantation of the permanent
    device will be made based on the response to the
    test stimulation

14
Implantation of the InterStim System
  • Procedure done in operating room using a light
    anesthesia on a same day surgery basis.
  • Stimulator is usually placed in upper buttock
  • The entire InterStim System will reside under the
    skin
  • Entire procedure takes less than one hour

15
How effective is this therapy?
Results 12 Months After Surgery
  • Urge Incontinence
  • 45 of patients completely dry
  • Further 34 had 50 or greater reduction in
    symptoms
  • Urgency-Frequency
  • 31 back to normal (4-7 per day)
  • Additional 33 had a 50 or more reduction in
    number of urinations
  • Retention
  • 61 stopped catherization
  • 16 had gt 50 reduction in the amount of urine
    emptied from the bladder by catheter

Medtronic clinical study data on file
16
Potential Risks with InterStim Therapy
  • As with other surgical procedures, there are
    risks
  • Pain
  • Infection
  • Transient electrical shock
  • Lead migration
  • These complications were generally resolvable in
    the clinical study

17
Does insurance pay for this?
  • National Medicare coverage policy.
  • Local coverage in the Twin Cities is excellent.

18
Pearls
  • Trans-obturator taping for stress incontinence
  • Highly effective, same day surgery.
  • InterStim for frequency and urge incontinence
  • Office procedure, well tolerated.
  • Medications are rarely the cure for incontinence.
  • Careful evaluation for an accurate diagnosis
  • Voiding diary, urodynamics.

19
Thank You Chase Kenyon Sovell, MD Urology
Associates, Ltd (952) 925-0473
Write a Comment
User Comments (0)
About PowerShow.com